Search
for

    Products matching "a values"

    Tracking 3 products like 257 RU58841 5% PG+ Ethanol, 260 RU58841 Powder and 260 RU58841 Powder from by companies like Anageninc. View all 3 products »

    Learn

    5 / 58 results

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women

      learn Vitamin D

      vitamin you should probably be taking for general health might also help your hair a little

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Peppermint

      herb and oil thought to stimulate skin and hair

      learn Hair Fibers

      cosmetic product that temporarily makes hair appear thicker

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results
      M27 Fin/Min (topical) was fun while it lasted

      community M27 Fin/Min (topical) was fun while it lasted

      in Finasteride  126 upvotes 3 months ago
      The user experienced significant hair regrowth using topical Minoxidil and Finasteride but had to stop due to high liver enzyme levels. They plan to pause treatment for a month to see if their liver values return to normal.

      community Progress - Min, Fin, and Nizoral.

      in Progress Pictures  340 upvotes 11 months ago
      The user shared progress photos showing hair regrowth after using Minoxidil, Finasteride, and Nizoral since mid-2023, and plans to replace derma rolling with Tretinoin. They discussed their routine, the initial shedding phase, and their experience with side effects, while others commented on the visible improvement.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.